Sloppy Sterility Seen At US OTC Ophthalmic Firm

Mexican Sanitizer Maker Also Warned About Sterile Conditions, Halts Production

Sterling Pharmaceutical’s Restricted Access Barrier Systems “permitted access to the processing line … without the design of rigid wall enclosures,” FDA says. Eksa Mills makes cleaning solutions with the same equipment in same facility and didn’t maintain written cleaning procedures or equipment use logs.

• Source: Shutterstock

An Illinois OTC ophthalmic drug manufacturer failed to convince the Food and Drug Administration it was keeping contaminants away from a sterile processing line and was advised to conduct a comprehensive evaluation of the effectiveness of its environmental monitoring.

A second OTC drug firm warned about not keeping production areas sufficiently sterile, a Mexican company, stopped making hand sanitizers...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Compliance

More from Policy & Regulation